ClinicalTrials.gov
public full text
Public Domain
Using of SGLt2 Inhibitors in Patients With Type 2 DM
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SGLT2 inhibitors: mechanisms, physiology and pharmacology, and clinical applications.#1167005
- Performance Under SGLT-2-Inhibitors in Humans#1033010
- The Triglyceride/Glucose Index and SGLT-2 Inhibitors#901366
- Knowledge, attitudes, and practices of Saudi physicians toward the use of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus: a nationwide cross-sectional study.#685447
- Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease#1114926
Record · ID 307391
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive